Regulus Therapeutics
RGLS
#8595
Rank
โ‚ฌ0.11 B
Marketcap
1,81ย โ‚ฌ
Share price
6.19%
Change (1 day)
-13.33%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -โ‚ฌ42.88 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚ฌ25.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ40.55 Million56.97%
2023 -โ‚ฌ25.83 Million6.51%
2022 -โ‚ฌ24.25 Million2.53%
2021 -โ‚ฌ23.65 Million93.59%
2020 -โ‚ฌ12.22 Million-15.41%
2019 -โ‚ฌ14.45 Million-64.46%
2018 -โ‚ฌ40.64 Million-33.26%
2017 -โ‚ฌ60.89 Million-13.98%
2016 -โ‚ฌ70.78 Million44.77%
2015 -โ‚ฌ48.89 Million-1.63%
2014 -โ‚ฌ49.71 Million203.6%
2013 -โ‚ฌ16.38 Million8.65%
2012 -โ‚ฌ15.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ3.85 B-9,611.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ6.96 B-17,290.56%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ1.67 B-4,225.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.15 B-22,682.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚ฌ0.21 Billion 409.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ86.39 Million 113.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ7.36 Billion 18,036.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.11 Billion 154.66%๐Ÿ‡บ๐Ÿ‡ธ USA